Citation Impact
Citing Papers
Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives
2013
Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors
2015
Foot-and-Mouth Disease Virus Virulent for Cattle Utilizes the Integrin α v β 3 as Its Receptor
1998
Cell Recognition by Foot-and-Mouth Disease Virus That Lacks the RGD Integrin-Binding Motif: Flexibility in Aphthovirus Receptor Usage
2000
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
2007 Standout
Combined chemokine and cytokine gene transfer enhances antitumor immunity
1996
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Modifications of the 5' untranslated region of foot-and-mouth disease virus after prolonged persistence in cell culture
1992
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
2009 StandoutNature
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Gene Therapy for Cancer: What Have We Done and Where Are We Going?
1997
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
1999 Standout
Imaging in the era of molecular oncology
2008 StandoutNature
Lung Cancer
2008 Standout
Development of a novel real-time RT-PCR assay for quantitation of foot-and-mouth disease virus in diverse porcine tissues
2001
Molecular basis of pathogenesis of FMDV
2003
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
2008 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Liposomes Containing Interferon-Gamma as Adjuvant in Tumor Cell Vaccines
2000
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
2009 StandoutNature
In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the α1,3galactosyltransferase gene
2005
Expression of α-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine
2003
EGF–ERBB signalling: towards the systems level
2006 Standout
Cationic Polymer Based Gene Delivery Systems
2000
Lung cancer: current therapies and new targeted treatments
2016 Standout
Assessing responses to cancer therapy using molecular imaging
2006
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
Surface modified magnetic nanoparticles for immuno-gene therapy of murine mammary adenocarcinoma
2012
Non-viral vectors for gene-based therapy
2014 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery
2003
Comparative analysis of immunocritical melanoma markers in the mouse melanoma cell lines B16, K1735 and S91-M3
2001
Intra‐tumoral Gene Delivery of feIL‐2, feIFN‐γ and feGM‐CSF using Magnetofection as a Neoadjuvant Treatment Option for Feline Fibrosarcomas: A Phase‐I Study
2007
Development of Transferrin-Polycation/DNA Based Vectors for Gene Delivery to Melanoma Cells
1999
Nanotechnology: Intelligent Design to Treat Complex Disease
2006
Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
1998
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo
2002
Photodynamic therapy and anti-tumour immunity
2006 Standout
HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine
2000 Standout
Inflammasomes: mechanism of assembly, regulation and signalling
2016 Standout
Autologous tumor vaccines processed to express ?-gal epitopes: a practical approach to immunotherapy in cancer
2004
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
2010 Standout
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
2009 Standout
Neuroblastoma
2007 Standout
Foot-and-Mouth Disease Virus Lacking the VP1 G-H Loop: The Mutant Spectrum Uncovers Interactions among Antigenic Sites for Fitness Gain
2001
Notch–RBP-J signaling is involved in cell fate determination of marginal zone B cells
2002 StandoutNobel
The Inflammasomes
2010 Standout
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes
1998 Standout
Comparison of the 5' and 3' untranslated genomic regions of virulent and attenuated foot-and-mouth disease viruses (strains O1 Campos and C3 Resende)
1991
Hepatitis C virus 3′UTR regulates viral translation through direct interactions with the host translation machinery
2013 StandoutNobel
IRES-driven translation is stimulated separately by the FMDV 3'-NCR and poly(A) sequences
2002
Insights into RNA Virus Mutant Spectrum and Lethal Mutagenesis Events: Replicative Interference and Complementation by Multiple Point Mutants
2007
The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response
2008 Nature
Beyond EGFR and ALK inhibition: Unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer
2015
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
2009 StandoutNature
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
1998
Foot-and-Mouth Disease
2004 Standout
A cis -Acting Replication Element in the Sequence Encoding the NS5B RNA-Dependent RNA Polymerase Is Required for Hepatitis C Virus RNA Replication
2004 StandoutNobel
Chemokines
1997 Standout
A Single Amino Acid Substitution in Nonstructural Protein 3A Can Mediate Adaptation of Foot-and-Mouth Disease Virus to the Guinea Pig
2001
Nonviral Vectors for Gene Delivery
2008 Standout
VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus
1992
The effect of particle design on cellular internalization pathways
2008 Standout
Deletion or substitution of the aphthovirus 3′ NCR abrogates infectivity and virus replication
2001
Replication of ONYX-015, a Potential Anticancer Adenovirus, Is Independent of p53 Status in Tumor Cells
1998 StandoutNobel
Somatic Mutations of the HER2 Kinase Domain in Lung Adenocarcinomas
2005
Cell-free tumor antigen peptide-based cancer vaccines
1997
Polylysine-based transfection systems utilizing receptor-mediated delivery
1998
Multiple Virulence Determinants of Foot-and-Mouth Disease Virus in Cell Culture
1998
Cationic Lipid-Mediated Gene Delivery to Murine Lung: Correlation of Lipid Hydration with in Vivo Transfection Activity
1997
Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice
1993
TLRs and innate immunity
2008 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Evidence for the role of His-142 of protein 1C in the acid-induced disassembly of foot-and-mouth disease virus capsids
1999
Immunobiology of Dendritic Cells
2000 Standout
Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma
2003
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.
1999
Point mutations within the betaG-betaH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells
1997
The Biology of Chemokines and their Receptors
2000 Standout
Functional analysis of the two alternative translation initiation sites of foot-and-mouth disease virus
1995
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Receptor-Mediated Uptake of Antigen/Heat Shock Protein Complexes Results in Major Histocompatibility Complex Class I Antigen Presentation via Two Distinct Processing Pathways
1999 StandoutNobel
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
2010 StandoutNobel
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer
2007 StandoutNobel
Heat Shock Protein 70 Induced During Tumor Cell Killing Induces Th1 Cytokines and Targets Immature Dendritic Cell Precursors to Enhance Antigen Uptake
1999
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus
2004
Functional interaction of translation initiation factor eIF4G with the foot-and-mouth disease virus internal ribosome entry site
2001
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Recombinant Adenovirus Induces Maturation of Dendritic Cells via an NF-κB-Dependent Pathway
2000
Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome
1993
Application of membrane-active peptides for nonviral gene delivery
1999
The α‐gal epitope and the anti‐Gal antibody in xenotransplantation and in cancer immunotherapy
2005
Identification and Characterization of a cis -Acting Replication Element ( cre ) Adjacent to the Internal Ribosome Entry Site of Foot-and-Mouth Disease Virus
2002
Works of Gerd Maass being referenced
Psoralen Treatment of Adenovirus Particles Eliminates Virus Replication and Transcription While Maintaining the Endosomolytic Activity of the Virus Capsid
1994
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene
1997
Gene transfer of costimulatory molecules B7–1 and B7–2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response
1997
Phase I Study to the Immunotherapy of Metastatic Malignant Melanoma by a Cancer Vaccine Consisting of Autologous Cancer Cells Transfected with the Human IL-2 Gene. University of Vienna, Austria
1996
Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parameters.
1995
Cancer vaccines: the interleukin 2 dosage effect.
1995
HER2 status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin.
2003
Tumor vaccines: Effects and fate of IL-2 transfected murine melanoma cells in vivo
1995
Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination.
1995
Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA
1990